Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10794)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2016 (publication date) through Sep 23, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu LJ, Xie SX, Chen YT, Xue JL, Zhang CJ, Zhu F. Aberrant regulation of Wnt signaling in hepatocellular carcinoma. World J Gastroenterol 2016; 22(33): 7486-7499 [PMID: 27672271 DOI: 10.3748/wjg.v22.i33.7486] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7486.htm |
| Number | Citing Articles |
| 1 |
S Mahmoud A Najafi. The Canonical Wnt Signaling (Wnt/β-Catenin Pathway): A Potential Target for Cancer Prevention and Therapy. Iranian Biomedical Journal 2020; 24(5): 264 doi: 10.29252/ibj.24.5.264
|
| 2 |
Kaushik Neogi, Prashant R. Murumkar, Priyanshu Sharma, Poonam Yadav, Mallika Tewari, Devarajan Karunagaran, Prasanta Kumar Nayak, Mange Ram Yadav. Design, synthesis and evaluation of 4,7-disubstituted 8-methoxyquinazoline derivatives as potential cytotoxic agents targeting β-catenin/TCF4 signaling pathway. Translational Oncology 2022; 19: 101395 doi: 10.1016/j.tranon.2022.101395
|
| 3 |
LILIANA PASLARU, PETRUTA ALEXANDRU, SANDA M. CRETOIU, SIMONA O. DIMA, IRINEL POPESCU. CRISPR/Cas9 gene editing in Huh7 and Hepa RG cell lines. Romanian Biotechnological Letters 2019; 24(2): 216 doi: 10.25083/rbl/24.2/216.228
|
| 4 |
Yinkai Xu, Daoming Shen, Jianxia Liu, Xiaolan Xu, Junhao Tu, Lei Qin, Liyang Jiang, Haixin Qian, Fengbao Guo. Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma. Journal of Molecular Histology 2020; 51(6): 659 doi: 10.1007/s10735-020-09912-6
|
| 5 |
Li-Juan Liu, Jian-Ming Liao, Fan Zhu. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2021; 13(10): 1425-1439 doi: 10.4251/wjgo.v13.i10.1425
|
| 6 |
Wanhu Fan, Fenjing Du, Xiaojing Liu. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling. European Journal of Pharmacology 2019; 850: 109 doi: 10.1016/j.ejphar.2019.01.054
|
| 7 |
Silvia Zappavigna, Alessia Maria Cossu, Anna Grimaldi, Marco Bocchetti, Giuseppe Andrea Ferraro, Giovanni Francesco Nicoletti, Rosanna Filosa, Michele Caraglia. Anti-Inflammatory Drugs as Anticancer Agents. International Journal of Molecular Sciences 2020; 21(7): 2605 doi: 10.3390/ijms21072605
|
| 8 |
Hiroyasu Sakai, Yasuhiro Yamada, Masaya Kubota, Kenji Imai, Yohei Shirakami, Hiroyuki Tomita, Akira Hara, Masahito Shimizu. The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway. Carcinogenesis 2022; 43(3): 254 doi: 10.1093/carcin/bgab099
|
| 9 |
Norihiko Yamamoto, Akiko Eguchi, Yoshifumi Hirokawa, Suguru Ogura, Kazushi Sugimoto, Motoh Iwasa, Masatoshi Watanabe, Yoshiyuki Takei. Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2020; 39(2): 57 doi: 10.1089/mab.2019.0050
|
| 10 |
Dimitrios N Samonakis, Elias A Kouroumalis. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World Journal of Hepatology 2017; 9(2): 80-90 doi: 10.4254/wjh.v9.i2.80
|
| 11 |
Kaushik Neogi, Mallika Tewari, AshishKumar Singh, Kavyanjali Sharma, GullankiNaga Venkata Charan Tej, SumitSingh Verma, SubashChandra Gupta, PrasantaKumar Nayak. Transcription factor 4 expression and correlation with tumor progression in gallbladder cancer. Journal of Cancer Research and Therapeutics 2022; 18(3): 668 doi: 10.4103/jcrt.jcrt_1381_21
|
| 12 |
Fei Cao, Li-Xue Yin. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. Experimental and Molecular Pathology 2019; 106: 34 doi: 10.1016/j.yexmp.2018.10.009
|
| 13 |
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential. International Journal of Molecular Sciences 2022; 23(3): 1234 doi: 10.3390/ijms23031234
|
| 14 |
William P. Harris, Kit Man Wong, Supriya Saha, Imane El Dika, Ghassan K. Abou-Alfa. Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers. Seminars in Oncology 2018; 45(3): 116 doi: 10.1053/j.seminoncol.2018.03.002
|
| 15 |
Juan Bayo, Esteban J. Fiore, Luciana M. Dominguez, Alejandrina Real, Mariana Malvicini, Manglio Rizzo, Catalina Atorrasagasti, Mariana G. García, Josepmaria Argemi, Elisabeth D. Martinez, Guillermo D. Mazzolini. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. Journal of Hepatology 2019; 71(1): 78 doi: 10.1016/j.jhep.2019.03.007
|
| 16 |
Sara Hooshmand, Mohammad Reza Mahdinezhad, Shirin Taraz Jamshidi, Mohammad Soukhtanloo, Farshad Mirzavi, Mehrdad Iranshahi, Maedeh Hasanpour, Ahmad Ghorbani. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytotherapy Research 2021; 35(6): 3365 doi: 10.1002/ptr.7056
|
| 17 |
Xiaoyun Hu, Guosheng Yuan, Qi Li, Jing Huang, Xiao Cheng, Jinzhang Chen. DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway. Annals of Medicine 2021; 53(1): 437 doi: 10.1080/07853890.2021.1898674
|
| 18 |
Sebastian Winkler, Ivana Winkler, Mirjam Figaschewski, Thorsten Tiede, Alfred Nordheim, Oliver Kohlbacher. De novo identification of maximally deregulated subnetworks based on multi-omics data with DeRegNet. BMC Bioinformatics 2022; 23(1) doi: 10.1186/s12859-022-04670-6
|
| 19 |
Shijing Yu, Ruirui Zhao, Bingchen Zhang, Chunmei Lai, Linyan Li, Jiangwen Shen, Xiarong Tan, Jingwei Shao. Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma. Asian Journal of Pharmaceutical Sciences 2023; 18(4): 100828 doi: 10.1016/j.ajps.2023.100828
|
| 20 |
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen. Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 2022; 34(24) doi: 10.1002/adma.202109210
|
| 21 |
Danping Huang, Bowen Yang, Yaoyao Yao, Mianmian Liao, Yu Zhang, Yihao Zeng, Fengxue Zhang, Neng Wang, Guangdong Tong. Autophagic Inhibition of Caveolin-1 by Compound Phyllanthus urinaria L. Activates Ubiquitination and Proteasome Degradation of β-catenin to Suppress Metastasis of Hepatitis B-Associated Hepatocellular Carcinoma. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.659325
|
| 22 |
Pan Jiang, Chaoqi Xu, Ming Zhou, Huaqun Zhou, Weida Dong, Xiaoyue Wu, Aochang Chen, Qing Feng. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC). Carcinogenesis 2018; 39(2): 252 doi: 10.1093/carcin/bgx138
|
| 23 |
Chrystelle L Vilfranc, Li-Xiao Che, Krushna C Patra, Liang Niu, Olugbenga Olowokure, Jiang Wang, Shimul A Shah, Chun-Ying Du. BIR repeat-containing ubiquitin conjugating enzyme (BRUCE) regulation of β-catenin signaling in the progression of drug-induced hepatic fibrosis and carcinogenesis. World Journal of Hepatology 2021; 13(3): 343-361 doi: 10.4254/wjh.v13.i3.343
|
| 24 |
Minjie Lin, Mengying Zhu, Tingqiu Ge, Naiying Lu, Xiling Fu, Jiabao Chang. Prognostic potential and mechanism of SORT1 and its co‐expressed genes in hepatocellular carcinoma based on integrative analysis of multiple database. Precision Medical Sciences 2022; 11(4): 161 doi: 10.1002/prm2.12084
|
| 25 |
Ying Long, Miaolong Lu, Tingting Cheng, Xiaohan Zhan, Xianquan Zhan. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00835
|
| 26 |
Xinglong Qu, Ying Tang, Shucheng Hua. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00563
|
| 27 |
Amit Kumar Singh, Shiv Vardan Singh, Ramesh Kumar, Shashank Kumar, Sabyasachi Senapati, Abhay K Pandey. Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise . World Journal of Hepatology 2023; 15(1): 1-18 doi: 10.4254/wjh.v15.i1.1
|
| 28 |
Mohammad Jaber MasodKhooy, Massoumeh Farasat, Mohamadreza Salehi Salmi, Hamed Mirzaei. Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma. Phytotherapy Research 2023; 37(5): 1968 doi: 10.1002/ptr.7716
|
| 29 |
Federico Selvaggi, Teresa Catalano, Rossano Lattanzio, Roberto Cotellese, Gitana Maria Aceto. Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities. World Journal of Gastroenterology 2023; 29(18): 2764-2783 doi: 10.3748/wjg.v29.i18.2764
|
| 30 |
Longqin Li, Yichao Zheng, Qi Zheng, Jiaji Jiang. Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1‑6 cells by embryonic stem cell‑conditioned medium. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8527
|
| 31 |
Li-Juan Liu, Zhao Lv, Xing Xue, Zhong-Yuan Xing, Fan Zhu. Canonical WNT Signaling Activated by WNT7B Contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by Inhibiting Mitophagy. Cancers 2022; 14(23): 5781 doi: 10.3390/cancers14235781
|
| 32 |
Adewale Oluwaseun Fadaka, Ashwil Klein, Ashley Pretorius. In silico identification of microRNAs as candidate colorectal cancer biomarkers. Tumor Biology 2019; 41(11): 101042831988372 doi: 10.1177/1010428319883721
|
| 33 |
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, Gitana Maria Aceto. Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents. Cancers 2022; 14(8): 1912 doi: 10.3390/cancers14081912
|
| 34 |
Jaime Arellanes-Robledo, Karina Reyes-Gordillo, Joseph Ibrahim, Leslie Leckey, Ruchi Shah, M. Raj Lakshman. Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro. Biochemical Pharmacology 2018; 156: 135 doi: 10.1016/j.bcp.2018.08.021
|
| 35 |
Jing Zhan, Liang-liang Shi, Yan Wang, Bai Wei, Sheng-li Yang. In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4738243
|
| 36 |
Chunmei Guo, Chao Gao, Dongting Zhao, Jiahui Li, Jinxia Wang, Xujuan Sun, Qinlong Liu, Lihong Hao, Frederick T. Greenaway, Yuxiang Tian, Shuqing Liu, Ming-Zhong Sun. A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01559-1
|
| 37 |
Maryam Navaeian, Hossein Ahmadpour-Yazdi, Samieh Asadian, Nematollah Gheibi. The effect of ANGPTL8 protein on proliferation and apoptosis in HepG2 hepatocellular carcinoma cell line. Gene Reports 2021; 25: 101306 doi: 10.1016/j.genrep.2021.101306
|
| 38 |
Kristy Chan, Regina Lo. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(1): 313 doi: 10.3390/ijms19010313
|
| 39 |
Elisavet Lioulia, Panagiotis Mokos, Emmanuel Panteris, Dimitra Dafou. UBE2T promotes β‐catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK‐dependent activation. Molecular Oncology 2022; 16(8): 1694 doi: 10.1002/1878-0261.13111
|
| 40 |
Shuai He, Shilei Tang. WNT/β-catenin signaling in the development of liver cancers. Biomedicine & Pharmacotherapy 2020; 132: 110851 doi: 10.1016/j.biopha.2020.110851
|
| 41 |
Jude Tetteh Quarshie, Kwadwo Fosu, Nicholas Awuku Offei, Augustine Kojo Sobo, Osbourne Quaye, Anastasia Rosebud Aikins. Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling. Pharmaceuticals 2023; 16(7): 1026 doi: 10.3390/ph16071026
|
| 42 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
| 43 |
Nur Rahadiani, Ignasia Andhini Retnowulan, Marini Stephanie, Diah Rini Handjari, Ening Krisnuhoni. β-Catenin Expression and Its Association with Prognostic Factors in Hepatocellular Carcinoma: A Study on Alpha-fetoprotein, Histologic Grade, and Microvascular Invasion. Open Access Macedonian Journal of Medical Sciences 2021; 9(A): 887 doi: 10.3889/oamjms.2021.6123
|
| 44 |
Xiaowen Mao, Sze Keong Tey, Frankie Chi Fat Ko, Ernest Man Lok Kwong, Yi Gao, Irene Oi-Lin Ng, Siu Tim Cheung, Xin-Yuan Guan, Judy Wai Ping Yam. C-terminal truncated HBx protein activates caveolin-1/LRP6/β-catenin/FRMD5 axis in promoting hepatocarcinogenesis. Cancer Letters 2019; 444: 60 doi: 10.1016/j.canlet.2018.12.003
|
| 45 |
Melek Pehlivan, Ceyda Caliskan, Zeynep Yuce, Hakki O. Sercan. sFRP1 Expression Regulates Wnt Signaling in Chronic Myeloid Leukemia K562 Cells. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(7): 1354 doi: 10.2174/1871520621666210524162145
|
| 46 |
Michael H Kagey, Xi He. Rationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology. British Journal of Pharmacology 2017; 174(24): 4637 doi: 10.1111/bph.13894
|
| 47 |
Rainbow Wing Hei Leung, Terence Kin Wah Lee. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022; 14(21): 5468 doi: 10.3390/cancers14215468
|
| 48 |
Caihao Qu, Tengda Ma, Xin YAN, Xiaomei Li, Yumin Li. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma. Mathematical Biosciences and Engineering 2022; 19(3): 3069 doi: 10.3934/mbe.2022142
|
| 49 |
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy. Advances in molecular oncology 2019; 5(4): 8 doi: 10.17650/2313-805X-2018-5-4-8-19
|
| 50 |
Katarzyna Kempinska, Bhavna Malik, Dmitry Borkin, Szymon Klossowski, Shirish Shukla, Hongzhi Miao, Jingya Wang, Tomasz Cierpicki, Jolanta Grembecka. Pharmacologic Inhibition of the Menin–MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2018; 17(1): 26 doi: 10.1158/1535-7163.MCT-17-0580
|
| 51 |
Simone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, Luca Fabris. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. World Journal of Hepatology 2017; 9(9): 455-468 doi: 10.4254/wjh.v9.i9.455
|
| 52 |
Yi-Ming Chang, Po-Chun Chen, Chien-Peng Hsu, Peng-Fang Ma, Huey-Ling Chen, Shu-Hao Hsu. Loss of hepatic miR-194 promotes liver regeneration and protects from acetaminophen-induced acute liver injury. Biochemical Pharmacology 2022; 195: 114862 doi: 10.1016/j.bcp.2021.114862
|
| 53 |
Kuntan Wu, Minjie Liu, Huanbin Wang, Shahid Ali Rajput, Omar Mahmoud Al Zoubi, Shuai Wang, Desheng Qi. Effect of zearalenone on aflatoxin B1-induced intestinal and ovarian toxicity in pregnant and lactating rats. Ecotoxicology and Environmental Safety 2023; 258: 114976 doi: 10.1016/j.ecoenv.2023.114976
|
| 54 |
Yangyang Hu, Chao Deng, He Zhang, Jing Zhang, Bo Peng, Chuanyi Hu. Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer. Oncotarget 2017; 8(55): 94554 doi: 10.18632/oncotarget.21791
|
| 55 |
M. Pehlivan, M. Soyoz, B. Cerci, H. I. K. Coven, Z. Yuce, H. O. Sercan. sFRP1 Expression Induces miRNAs That Modulate Wnt Signaling in Chronic Myeloid Leukemia Cells. Molecular Biology 2020; 54(4): 563 doi: 10.1134/S0026893320040135
|
| 56 |
Dilip K. Patel, Roohi Kesharwani, Amita Verma, Fahad A. Al-Abbasi, Firoz Anwar, Vikas Kumar. Scope of Wnt signaling in the precise diagnosis and treatment of breast cancer. Drug Discovery Today 2023; 28(7): 103597 doi: 10.1016/j.drudis.2023.103597
|
| 57 |
Al Shaima G. Abd El Salam, Yara A. Samra, Mamdouh M. El-Shishtawy. Cinnamaldehyde Relieves Induced Hepatocellular Carcinoma in Rat Model via Targeting Wnt/β-Catenin Pathway. Scientia Pharmaceutica 2022; 90(2): 22 doi: 10.3390/scipharm90020022
|
| 58 |
Melek Pehlivan, Ceyda Çalışkan, Zeynep Yüce, Hakki Ogun Sercan. Secreted Wnt antagonists in leukemia: A road yet to be paved. Leukemia Research 2018; 69: 24 doi: 10.1016/j.leukres.2018.03.011
|